1. United Kingdom Stocks

  2. •

    Healthcare

  3. •

    Drug Manufacturers - Specialty & Generic
Animalcare Group plc

Animalcare Group plc

ANCR.L
Animalcare Group plcGB flagLondon Stock Exchange
331.50
GBp
- -
- -
228.89MMarket Cap
Animalcare Group plc
ANCR.L
(London Stock Exchange)

Recent

price

331.50

P/E

ratio

- -

div

yld

- -

ROIC.AI

2011
2012
2013
2014
2015
2016
2017
2017
2018
2019
2020
2021
2022
2023
2024
2025
FRC
0.58
0.53
0.58
0.62
0.65
0.7
- -
- -
1.21
1.18
1.17
1.23
1.19
1.18
1.21
1.29
Revenue per Share
0.11
0.08
0.09
0.1
0.12
0.13
- -
- -
-0.02
-0.02
- -
- -
0.03
0.02
0.3
0.07
Basic EPS, GAAP
0.1
0.09
0.11
0.04
0.15
0.12
- -
- -
0.04
0.18
0.14
0.18
0.11
0.14
0.14
0.11
Free Cash Flow per Basic Share
0.04
0.05
0.04
0.05
0.06
0.06
- -
- -
0.04
0.04
0.02
0.04
0.04
0.04
0.05
0.05
Dividend per Share
0.48
0.52
0.57
0.63
0.69
0.76
- -
- -
0.12
0.06
0.04
0.01
- -
-0.01
0.29
0.28
Book Value per Share
0.06
0.12
0.18
0.26
0.31
0.32
- -
- -
-0.26
-0.19
-0.12
-0.03
0.05
0.11
0.94
-0.03
Tangible Book Value per Share
20
21
21
21
21
21
21
42
60
60
60
60
60
60
61
69
Basic Weighted Avg Shares
12
11
12
13
14
15
- -
- -
72
71
70
74
72
71
74
89
Sales/Revenue/Turnover
24.82
19.38
18.91
20.83
22.98
21.7
- -
- -
4.83
4.98
3.94
6.4
5.79
5.68
9.54
6.96
Operating Margin (%)
- -
- -
- -
- -
- -
- -
- -
- -
8
9
9
8
8
8
7
9
Depreciation Expense
2
2
2
2
3
3
- -
- -
-1
-1
- -
- -
2
1
18
5
Net Income, GAAP
23.05
17.9
19.1
20.02
15.81
14.65
- -
- -
- -
- -
- -
108.15
22.7
66.6
16.7
19.94
Effective Tax Rate (%)
19.66
15.93
15.56
16.59
18.72
17.92
- -
- -
-1.37
-1.88
0.33
-0.1
2.74
1.7
24.92
5.7
Profit Margin (%)
2
3
4
6
7
8
- -
- -
19
13
10
10
12
11
77
13
Working Capital
- -
- -
- -
- -
- -
- -
- -
- -
31
23
17
10
11
5
21
12
LT Debt
16
17
18
19
21
23
- -
- -
87
82
82
79
79
78
113
115
Total Equity
12.76
10.24
10.29
11.08
12.56
12.19
- -
- -
- -
- -
- -
-0.4
3.5
1.51
5.26
3.67
Return on Invested Capital (%)
21.18
16.94
16.8
17.21
18.37
17.25
- -
- -
- -
- -
- -
-0.69
21.1
17.47
81.37
15.3
Return on Capital (%)
25.99
16.94
16.8
17.21
18.37
17.25
- -
- -
-27.36
-25.12
7.88
-5.29
1,020.78
- -
- -
27.16
Return on Common Equity (%)

Capital Structure

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

•

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

•

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
8.4%
1.08%
Free Cash Flow
- -
0.78%
-9.35%
Net Income, GAAP
- -
-290.79%
-72.54%
Sales/Revenue/Turnover
- -
5.1%
20.04%
Total Cash Common Dividend
- -
- -
18.81%

Quarterly Revenue

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
71
2024
- -
- -
- -
- -
74
2025
- -
- -
- -
- -
89

Quarterly Earnings Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.02
2024
- -
- -
- -
- -
0.3
2025
- -
- -
- -
- -
0.07

Quarterly Dividends Per Share

FRC

•

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
0.04
2024
- -
- -
- -
- -
0.05
2025
- -
- -
- -
- -
0.05
Similar Companies
Livzon Pharmaceutical Group Inc. (1513.HK)
Valeo Pharma Inc. (VPHIF)
Wakamoto Pharmaceutical Co.,Ltd. (4512.T)
Celon Pharma S.A. (CLN.WA)
Evolus, Inc. (EOLS)
Global Hemp Group Inc. (GHG.CN)
Business
Animalcare Group plc is an international veterinary sales and marketing company that develops, commercializes and distributes prescription and over-the-counter pharmaceutical products, identification services and related offerings to improve animal health and wellbeing for companion animals, production animals and equine markets. The company offers a focused portfolio of high-margin brands including Daxocox, a long-acting COX-2 inhibitor NSAID for chronic osteoarthritic pain in dogs; Plaqtiv+, a biofilm-targeting dental care range; Orozyme dental hygiene products; Danilon, an anti-inflammatory treatment for equine; fluids and other equine therapeutics; dermatological treatments via partnerships such as Yun Probiotherapy; production animal pharmaceuticals with emphasis in southern Europe; and microchipping and companion animal identification services. It operates through direct commercial presence in seven European countries including the UK, Belgium, France and others, exports to more than 40 markets worldwide, and following the January 2025 completion of its transformational acquisition of Randlab Australia Pty Ltd and subsidiaries for approximately £60m, now maintains operations in Australia and New Zealand to strengthen its equine portfolio and enable expansion into Asia Pacific. Founded in 1972 and headquartered in York, United Kingdom, Animalcare Group plc lists on the UK AIM exchange (ANCR.L) and pursues growth via its development pipeline, in-licensing, partnerships and acquisitions.